Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials
- Resource Type
- Source
- The Lancet Child & Adolescent Health. 7:180-189
- Subject
Pediatrics, Perinatology and Child Health Developmental and Educational Psychology - Language
- ISSN
- 2352-4642